JOHN SMETANA: Open Payments
NPI 1164851457 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 6 payments from 4 companies in 2025. Trend: 2023 $252 · 2024 $180 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: COBENFY, INGREZZA, UZEDY.
Industry payments across ND — which companies pay providers there.
